By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology





Company News
Spectrum Pharma (SPPI) Announces Initiation Of The Registrational Phase III Trial Of Qapzola (Apaziquone) In Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) 8/14/2017 6:34:58 AM
Spectrum Pharma (SPPI) Reports Second Quarter 2017 Financial Results And Pipeline Update 8/4/2017 7:58:47 AM
Spectrum Pharma (SPPI) Announces Completion Of Enrollment In The Phase III Pivotal Study (ADVANCE) Of ROLONTIS (Eflapegrastim), A Novel Long-Acting GCSF 8/1/2017 7:30:07 AM
Spectrum Pharma (SPPI) Announces Second Quarter 2017 Financial Results Teleconference And Webcast 7/27/2017 6:28:23 AM
Spectrum Pharma (SPPI) Highlights Results Of A Combination Study Of FOLOTYN (Pralatrexate Injection) Plus Romidepsin Presented At The 14th International Conference On Malignant Lymphoma (14-ICML) Meeting 6/19/2017 9:05:01 AM
Spectrum Pharma (SPPI) Highlights Three Abstracts Of Clinical Data At The 2017 ASCO Annual Meeting In Chicago, Illinois, June 2-6, 2017 6/2/2017 7:13:12 AM
Spectrum Pharma (SPPI) Reports First Quarter 2017 Financial Results And Pipeline Update 5/3/2017 5:47:09 AM
Spectrum Pharma (SPPI) Announces First Quarter 2017 Financial Results Teleconference And Webcast 4/25/2017 6:24:11 AM
Spectrum Pharma (SPPI) Highlights Preclinical Data Of ROLONTIS (Eflapegrastim) At The AACR Annual Meeting 4/4/2017 7:51:35 AM
Spectrum Pharma (SPPI) Announces Initiation Of A Phase II Trial Of Poziotinib In Non-Small Cell Lung Cancer Patients With EGFR Exon 20 Insertion Mutations 3/30/2017 6:22:41 AM
12345678910...
//-->